| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 23,850,300 | 24,197,700 | 22,636,000 | | Cost of Revenue | 5,582,500 | 6,140,700 | 6,001,100 | | | Gross Profit | 18,267,800 | 18,057,000 | 16,634,900 | | | Operating Expenses | | Research Development | 4,805,300 | 4,882,800 | 4,782,900 | | Selling General and Administrative | 7,377,000 | 7,556,700 | 8,165,400 | | Non Recurring | 1,032,500 | 5,177,100 | 142,300 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,053,000 | 440,400 | 3,544,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,445,500 | 459,500 | 878,300 | | Earnings Before Interest And Taxes | 10,059,100 | 3,755,000 | 6,596,500 | | Interest Expense | 251,300 | 384,300 | 375,100 | | Income Before Tax | 9,807,800 | 3,370,700 | 6,221,400 | | Income Tax Expense | 1,999,400 | 95,300 | 1,787,600 | | Minority Interest |
-
| (121,400) | (120,500) | | | | Net Income From Continuing Ops | 7,808,400 | 3,275,400 | 4,433,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 7,808,400 | 3,275,400 | 4,433,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,808,400 | $3,275,400 | $4,433,800 |
|
0.16% Nasdaq 0.00%
Income Statement
